M Bishr Omary Selected Research

Porphyrias (Porphyria)

1/2021	Protein-aggregating ability of different protoporphyrin-IX nanostructures is dependent on their oxidation and protein-binding capacity.
1/2019	Loss of hepatocyte β-catenin protects mice from experimental porphyria-associated liver injury.
1/2019	Oxygen and Conformation Dependent Protein Oxidation and Aggregation by Porphyrins in Hepatocytes and Light-Exposed Cells.
1/2019	Porphyrin-Induced Protein Oxidation and Aggregation as a Mechanism of Porphyria-Associated Cell Injury.
6/2017	Intermediate filament proteins of digestive organs: physiology and pathophysiology.
1/2016	A precursor-inducible zebrafish model of acute protoporphyria with hepatic protein aggregation and multiorganelle stress.
9/2015	Ambient Light Promotes Selective Subcellular Proteotoxicity after Endogenous and Exogenous Porphyrinogenic Stress.
7/2013	Lamin aggregation is an early sensor of porphyria-induced liver injury.
4/2010	Gender dimorphic formation of mouse Mallory-Denk bodies and the role of xenobiotic metabolism and oxidative stress.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

M Bishr Omary Research Topics

Disease

33	Liver Diseases (Liver Disease) 01/2018 - 02/2002
15	Fibrosis (Cirrhosis) 11/2023 - 05/2003
9	Porphyrias (Porphyria) 01/2021 - 04/2010
8	End Stage Liver Disease 11/2023 - 09/2005
8	Neoplasms (Cancer) 10/2019 - 09/2003
8	Pancreatitis 01/2018 - 10/2004
7	Acute Liver Failure (Fulminant Hepatic Failure) 11/2023 - 09/2010
6	Non-alcoholic Fatty Liver Disease 01/2023 - 11/2013
6	Chronic Hepatitis C 01/2012 - 06/2006
5	Fatty Liver 01/2018 - 11/2003
5	Colitis 06/2015 - 03/2004
5	Inflammation (Inflammations) 12/2014 - 03/2004
5	Infections 01/2012 - 08/2004
4	Epidermolysis Bullosa Simplex (Epidermolysis Bullosa Herpetiformis Dowling Meara) 12/2023 - 12/2022
4	Hepatocellular Carcinoma (Hepatoma) 01/2019 - 08/2003
4	Liver Cirrhosis (Hepatic Cirrhosis) 11/2017 - 05/2003
3	Skin Diseases (Skin Disease) 12/2023 - 07/2003
3	Chemical and Drug Induced Liver Injury 01/2023 - 05/2003
3	Laminopathies 01/2020 - 07/2013
3	Liver Failure 01/2019 - 01/2013
3	Hypoxia (Hypoxemia) 01/2018 - 10/2012
3	Necrosis 01/2016 - 01/2013
3	Disease Progression 08/2009 - 05/2005
2	Insulin Resistance 01/2023 - 12/2013
2	Rare Diseases (Rare Disease) 01/2021 - 01/2020
2	Virus Diseases (Viral Diseases) 01/2016 - 09/2005
2	Erythropoietic Protoporphyria 09/2015 - 07/2012
2	Starvation 06/2015 - 06/2006
2	Neoplasm Metastasis (Metastasis) 02/2015 - 09/2003
2	Hepatitis C 11/2013 - 10/2011
2	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 01/2012 - 08/2009
2	Hyperplasia 01/2011 - 03/2004
2	Chronic Pancreatitis 04/2008 - 05/2006
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 07/2007 - 05/2006
2	Adenocarcinoma 06/2007 - 09/2006
2	Barrett Esophagus (Barrett's Esophagus) 06/2007 - 09/2006
1	Pachyonychia Congenita (Jadassohn-Lewandowsky Syndrome) 12/2023
1	Hyponatremia 10/2023
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 12/2022
1	Systemic Mastocytosis 12/2022
1	Cholestasis 01/2022
1	Erythropoietic Porphyria (Congenital Erythropoietic Porphyria) 01/2021
1	Inborn Genetic Diseases (Disease, Hereditary) 01/2021

Drug/Important Bio-Agent (IBA)

46	Keratins (Keratin)IBA 12/2023 - 02/2002
24	K-18 conjugate (K18)IBA 01/2023 - 05/2003
16	Proteins (Proteins, Gene)FDA Link 10/2023 - 05/2003
10	Keratin-8 (Keratin 8)IBA 12/2015 - 05/2003
6	EnzymesIBA 11/2023 - 11/2005
6	LaminsIBA 01/2023 - 07/2013
6	Phosphotransferases (Kinase)IBA 12/2022 - 03/2002
6	PorphyrinsIBA 01/2021 - 09/2015
5	Acetaminophen (Paracetamol)FDA LinkGeneric 11/2023 - 09/2010
5	Heme (Haem)IBA 01/2021 - 01/2016
4	Lamin Type A (Lamin A)IBA 01/2023 - 06/2017
4	AntibodiesIBA 10/2019 - 08/2003
4	CeruletideIBA 01/2018 - 10/2004
4	Keratin-18 (Keratin 18)IBA 12/2015 - 08/2003
4	DNA (Deoxyribonucleic Acid)IBA 09/2006 - 05/2003
3	Biomarkers (Surrogate Marker)IBA 11/2023 - 01/2016
3	protoporphyrin IXIBA 01/2019 - 09/2015
3	NF-kappa B (NF-kB)IBA 01/2018 - 10/2004
3	Transcription Factors (Transcription Factor)IBA 01/2018 - 10/2012
3	LipidsIBA 01/2016 - 09/2003
3	CaspasesIBA 01/2016 - 04/2011
3	Intermediate Filament ProteinsIBA 12/2015 - 03/2005
3	Messenger RNA (mRNA)IBA 11/2013 - 10/2004
3	Hemin (Panhematin)FDA Link 05/2011 - 11/2005
2	ImmunosorbentsIBA 11/2023 - 01/2016
2	Nuclear Proteins (Protein, Nuclear)IBA 01/2023 - 07/2013
2	Adenosine (Adenocard)FDA LinkGeneric 10/2019 - 11/2013
2	5'-Nucleotidase (5' Nucleotidase)IBA 10/2019 - 12/2014
2	CateninsIBA 01/2019 - 06/2013
2	Deferoxamine (Desferal)FDA LinkGeneric 01/2019 - 09/2015
2	Oxygen (Dioxygen)IBA 01/2018 - 10/2012
2	Ethanol (Ethyl Alcohol)IBA 01/2018 - 10/2012
2	BuffersIBA 11/2017 - 07/2013
2	Choline (Choline Chloride)IBA 01/2017 - 11/2005
2	EpitopesIBA 01/2016 - 02/2006
2	AcidsIBA 09/2015 - 06/2007
2	UbiquitinIBA 11/2013 - 09/2008
2	sphingosine phosphorylcholineIBA 05/2012 - 09/2003
2	Amino Acids FDA Link 01/2012 - 05/2006
2	Alanine Transaminase (SGPT)IBA 10/2011 - 04/2011
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2011 - 05/2005
2	Heme Oxygenase-1IBA 01/2011 - 11/2005
1	Ligases (Synthetase)IBA 11/2023
1	Carbamyl Phosphate (Carbamoyl Phosphate)IBA 11/2023
1	Urea (Carbamide)FDA LinkGeneric 10/2023
1	Carrier Proteins (Binding Protein)IBA 01/2023
1	parthenolideIBA 01/2023
1	midostaurinIBA 12/2022
1	isothiocyanic acidIBA 01/2022
1	Uroporphyrinogen III Synthetase (Uroporphyrinogen-III Synthase)IBA 01/2021
1	Acitretin FDA Link 01/2021
1	coproporphyrin IIBA 01/2021
1	Polysaccharides (Glycans)IBA 10/2019

Therapy/Procedure

5	Therapeutics 12/2023 - 05/2005
1	Ligation 01/2022
1	Bone Marrow Transplantation (Transplantation, Bone Marrow) 01/2021
1	Immunotherapy 10/2019